Page last updated: 2024-12-05

beryllium oxide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

beryllium oxide : A beryllium molecular entity consisting of beryllium (+2 oxidation state) and oxide in the ratio 1:1. In the solid state, BeO adopts the hexagonal wurtzite structure form while in the vapour phase, it is present as discrete diatomic covalent molecules. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID14775
CHEBI ID62842
MeSH IDM0102006

Synonyms (23)

Synonym
1304-56-9
ec 215-133-1
unii-2s8nlr37s3
einecs 215-133-1
beryllium oxide (beo)
ccris 83
bromellete
beryllium monoxide
thermalox 995
natural bromellite
beryllia
thermalox
hsdb 1607
beryllium oxide
beryllium oxide, 99.98% trace metals basis
oxoberyllium
CHEBI:62842
AKOS015903963
21883-51-2
DTXSID30872818
mfcd00003457
beryllium oxide, purum
Q422714

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
" To avoid errors in predicting bioavailability of beryllium and the associated risks for CBD, the mechanisms of particle formation should be understood and the SSA of beryllium particles should be measured directly."( Surface area of respirable beryllium metal, oxide, and copper alloy aerosols and implications for assessment of exposure risk of chronic beryllium disease.
Breysse, PN; Day, GA; Dickerson, RM; Hoover, MD; Kent, MS; Peterson, EJ; Scripsick, RC; Stefaniak, AB,
)
0.13
" These findings demonstrate a mechanism of bioavailability for beryllium, are consistent with previously observed results in canine alveolar macrophages, and provide insights into additional research needs to understand and prevent beryllium sensitization and CBD."( Bioavailability of beryllium oxide particles: an in vitro study in the murine J774A.1 macrophage cell line model.
Day, GA; Dickerson, RM; Esmen, NA; Hoover, MD; Peterson, EJ; Scripsick, RC; Stefaniak, AB, 2005
)
0.66

Dosage Studied

ExcerptRelevanceReference
" 4) Examination of the frequency in terms of BeO dosages revealed no results suggesting the dose-response relationship between pulmonary granuloma formation and the dosage."( [Studies on the effects of beryllium oxide in purity and fired temperature to the occurrence of chronic pulmonary berylliosis].
Kato, Y; Kogame, Y; Kurita, H; Miki, T; Shima, S; Tachikawa, S; Watanabe, K; Yoshida, T, 1983
)
0.56
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
carcinogenic agentA role played by a chemical compound which is known to induce a process of carcinogenesis by corrupting normal cellular pathways, leading to the acquistion of tumoral capabilities.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
beryllium molecular entity
metal oxideAn inorganic oxide that is an oxide of any metal.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (81)

TimeframeStudies, This Drug (%)All Drugs %
pre-199030 (37.04)18.7374
1990's8 (9.88)18.2507
2000's20 (24.69)29.6817
2010's20 (24.69)24.3611
2020's3 (3.70)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 73.76

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index73.76 (24.57)
Research Supply Index4.45 (2.92)
Research Growth Index4.67 (4.65)
Search Engine Demand Index125.40 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (73.76)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (2.35%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other83 (97.65%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]